FEVAXYN FeLV Cat Vaccine 25x1ml vials
Suggested for vaccination among healthy cats, so as to avoid lymphoid tumors caused by, and diseases related wit, feline leukemia virus (FeLV) infection, the FEVAXYN FeLV Cat Vaccine 25x1ml vials prevents persistent viremia in cats exposed to virulent feline leukemia virus. The Fevaxyn FeLV vaccine comprises of a tissue culture derived feline leukemia virus, Subgroups A and B. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to augment the immune response.
· Vaccine designed for healthy cats
· Protects against the diseases caused by feline leukemia virus
· Chemically inactivated and combined with a proprietary adjuvant designed to augment the immune response
Initial vaccination: Inject 1 dose (1 ml) subcutaneously or intramuscularly at 9 weeks of age or older.
Second vaccination: Inject 1 dose (1 ml) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination
Two doses are required for primary immunization.
Annual revaccination with one dose is recommended.
Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following vaccination. Prior
exposure to the disease, or disease latency, are conditions in which vaccination will not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen prior to vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency (FIV), another feline retrovirus. It is important to advise the cat owner of these situations prior to vaccination.
· Store at 2°-7°C
· Do not freeze
· Do not mix with other vaccines
· Use new, non-chemically sterilized needles and syringes